TMS for Anxiety and Depression: Evidence and Limits
TMS for anxiety and depression can improve depression and accompanying anxiety symptoms in some adults with major depressive disorder. For example, the FDA-cleared NeuroStar indication includes reducing anxiety symptoms in adults with major depressive disorder who have not improved enough with prior antidepressant treatment in the current episode. That is a specific clinical situation, not a blanket claim that one TMS protocol treats every anxiety disorder. [1]
If both low mood and anxiety are affecting your life, the first step is to clarify what each symptom pattern represents. A useful treatment plan names the problems being treated, explains the evidence, and tracks improvement in both areas.
TMS for anxiety: why the diagnosis matters
“Anxiety” can describe a temporary feeling, a symptom during a depressive episode, or a separate clinical disorder. Those meanings can overlap, but they are not interchangeable. Depression itself can involve restlessness, irritability, difficulty concentrating, and sleep changes. Generalized anxiety disorder can also involve several of those symptoms.
A clinician therefore needs more than a checklist that says both anxiety and depression are present. The timing, persistence, triggers, and effect on daily life help establish what needs treatment.
Anxiety symptoms that accompany depression
Someone with major depressive disorder may also feel tense, worry frequently, or find it difficult to relax. Clinicians and researchers may describe this as anxious depression, although studies do not all define that term in the same way. The TMS evidence discussed here concerns anxiety symptoms in people who also have major depressive disorder.
That distinction matters when reading a headline such as “TMS treats anxiety.” Ask whether the study involved depression with anxiety symptoms or people whose main diagnosis was an anxiety disorder without depression. Results from one group do not automatically answer questions about the other.
A separate anxiety disorder
An anxiety disorder involves a pattern that needs its own assessment. Generalized anxiety disorder, for example, includes persistent, difficult-to-control worry about multiple areas of life. A person can have this disorder and major depression at the same time.
The anxiety service information is a starting point for discussing these concerns. You do not need to decide the correct diagnosis before asking for help, and you should not delay seeking care until symptoms fit an online description perfectly.
NIMH's short video explains the difference between occasional anxiety and symptoms that persist and interfere with life. It supports understanding the anxiety part of the assessment; it does not make claims about TMS.
Watch the video: Mental Health Minute: Anxiety Disorders in Adults (National Institute of Mental Health (NIMH))
Other concerns that can be described as anxiety
Tell the clinician about the experiences behind the label. Panic-like episodes, distressing repetitive thoughts or rituals, and trauma-related symptoms deserve specific discussion. If the assessment identifies OCD or PTSD, ask how that diagnosis changes the plan. The device indication for depression with anxiety symptoms should not be assumed to cover either condition. [1]
Likewise, new or unexplained physical symptoms should not automatically be attributed to anxiety. A mental health assessment can be coordinated with medical evaluation when needed. [3]
Is TMS cleared for depression with anxiety symptoms?
The FDA's NeuroStar clearance record describes treatment of depressive episodes and reduction of comorbid anxiety symptoms in adults with major depressive disorder after an inadequate response to previous antidepressant treatment in the current episode. “Comorbid” means that the symptoms or conditions occur together.
The precise wording sets limits. It identifies the device, adult population, depressive diagnosis, accompanying anxiety symptoms, and prior treatment context. It is FDA clearance for a medical device, rather than drug approval. It does not establish that any person with worry qualifies for the treatment.
Sophroneo's NeuroStar TMS page identifies its listed offering. During a consultation, ask which indication and protocol apply to you. If TMS is being proposed primarily for a separate anxiety disorder, ask whether that particular use is within the device's labeling, off-label, or investigational, and what evidence supports it.
These are also separate from insurance questions. A clinician's recommendation does not establish coverage, and an insurer's authorization is not a personalized prediction of benefit.
Does TMS help anxiety as well as depression?
The regulatory record includes evidence that anxiety symptoms can improve during TMS treatment for major depression. The findings concern anxiety measured within depression populations, not proof that all primary anxiety disorders respond to the same treatment. [1]
A 2023 analysis of the NeuroStar clinical outcomes registry examined people with major depressive disorder who had both depression and anxiety questionnaires available. Mood and anxiety scores often improved together. However, it was a retrospective analysis of routine care, without a randomized sham-treatment comparison. It cannot by itself establish how much improvement was caused by TMS or predict an individual's result.
The study also used a questionnaire threshold to define its anxious-depression group. A high questionnaire score is useful information about symptoms; it is not equivalent to a full diagnosis of generalized anxiety disorder. [4]
Clinical question | What can reasonably be said |
Can anxiety improve when TMS is used for major depression? | Yes, evidence and a specific device clearance support that possibility in the defined adult population. |
Does that mean every anxiety disorder has the same indication? | No. The diagnosis, device, protocol, and labeling need separate review. |
Will mood and anxiety improve equally for one person? | There is no individual guarantee. Both should be tracked. |
Does a success story establish the likely outcome? | No. A personal account cannot replace evidence and clinical assessment. |
These distinctions allow a hopeful discussion without promising that one procedure will resolve every source of distress.
How does TMS fit into the treatment plan?
TMS delivers magnetic pulses through a coil near the scalp. These stimulate brain regions and connected networks involved in mood. Treatment is performed while the patient is awake and does not routinely require anesthesia. Its antidepressant effects are not adequately explained as simply switching off fight-or-flight or resetting a single anxiety circuit. [5]
A conventional course commonly involves visits on most weekdays for several weeks, although protocols vary. Before committing, discuss the treatment schedule, travel, work or caregiving obligations, and how follow-up will be handled. A manageable plan is part of an informed decision. [5]
The TMS candidacy page can help organize an assessment conversation. Bring records of prior treatment and explain which symptoms improved, which persisted, and which side effects made care difficult. “It did not work” becomes much more useful when the clinician understands what happened.
Tracking depression and anxiety symptoms during TMS
They should be assessed separately as well as together. A general impression of feeling better can miss an important difference between mood and anxiety. For example, a person might regain some interest in activities while still finding worry difficult to manage. That is a possible pattern to monitor, not a predicted sequence of recovery.
Clinicians may use measures such as the PHQ-9 for depressive symptoms and the GAD-7 for anxiety symptoms. These questionnaires can help compare symptoms over time, but they do not replace the interview or establish every diagnosis. The registry research used both measures, which allowed it to examine change in each domain.
Discuss how the team will interpret the results. The article on tracking TMS progress also emphasizes everyday functioning. A meaningful review might ask whether you can concentrate at work, participate in a conversation, begin a routine task, or approach an activity you had been avoiding.
Choose a few concrete goals rather than a long daily scorecard. Ask the clinician how often to record them and when the treatment plan will be formally reviewed. If a score improves but your most important difficulty persists, that mismatch should be discussed.
Sleep is another useful part of the conversation. Ongoing trouble sleeping may deserve a separate insomnia assessment, rather than being treated only as a marker of whether TMS has succeeded. Sleep symptoms can accompany both depression and anxiety, and their cause needs clinical consideration.
What if depression improves but anxiety remains?
The remaining anxiety deserves treatment in its own right. The next step is to reassess what is driving it and whether the original plan addressed that problem adequately. It should not be dismissed because another symptom measure improved.
For generalized anxiety disorder, established treatment options include psychotherapy, such as cognitive behavioral therapy, and medication when appropriate. A clinician may recommend one approach or a combination based on symptoms, preferences, previous response, and medical history. TMS for depression does not remove the need for anxiety-specific care.
You can also continue discussing practical obstacles: avoiding appointments, difficulty tolerating uncertainty, or worry about treatment sensations. Naming these concerns gives the team something concrete to address. It does not mean that persistent symptoms are a lack of effort or that you should simply relax.
If medication is part of the plan, coordinate any changes with the prescriber. Do not stop an antidepressant or anxiety medication independently because TMS itself does not deliver a drug.
Could treatment feel uncomfortable or make anxiety harder to manage?
TMS can involve loud clicking, scalp tapping, discomfort, or headache. A seizure is a rare potential adverse effect. Anxiety about an unfamiliar procedure is a reasonable topic for the clinical team, and new or worsening symptoms during a course should be reported.
Ask the team to explain what you will hear and feel, how hearing protection is used, and how to signal discomfort. Tell them if worry is making it difficult to attend or remain comfortable during sessions. A plan for communication is more useful than a promise that the procedure is painless.
Screening should include relevant medical history, seizure risk, implanted devices or metal near the head, and current medications or substances. Also report major changes in sleep, agitation, or mood. The clinician can decide whether a symptom reflects the illness, treatment, another health issue, or a reason to change the plan.
If depression becomes unsafe or includes thoughts of suicide, call or text 988 in the United States. For immediate physical danger or a life-threatening emergency, call 911 or seek emergency care rather than waiting for a routine visit.
How useful are patient stories when deciding?
A personal account may help you identify questions about daily appointments, hopes, or treatment burden. It cannot establish what will happen to you. The person's diagnosis, device, protocol, other treatments, and follow-up may differ from yours.
When a story says both anxiety and depression disappeared, ask what was actually measured and over what period. Was anxiety a symptom, a diagnosed disorder, or the speaker's description of distress? Was the improvement sustained? Were other treatments continued? The same questions are useful when a story reports no benefit.
Clinical research and patient experience contribute different kinds of information. A sound decision uses relevant evidence and an individualized assessment while making space for your own preferences and concerns.
Questions that make the consultation more useful
Bring a short symptom timeline and prior treatment list. Then ask:
What diagnoses best explain my depression and anxiety symptoms?
Which device and indication are you proposing for me?
What evidence applies to someone with my particular symptom pattern?
How will we measure depression, anxiety, daily functioning, and side effects separately?
What will we do if only one area improves or the treatment does not help enough?
Which parts of my current care should continue, and who will coordinate follow-up?
A depression care discussion should leave you with a clearer plan for the whole problem. TMS may be one useful part of that plan, especially when major depression and accompanying anxiety symptoms persist despite prior treatment, but an individualized recommendation should explain its limits as well as its potential.
To discuss those questions with the practice, contact Sophroneo Behavioral Health & TMS. This article is educational and cannot determine your diagnosis or eligibility.
Frequently Asked Questions
Does a high GAD-7 score mean I qualify for TMS?
No. A symptom score is not a diagnosis or an eligibility decision. Assessment should establish the clinical conditions, prior treatment, safety factors, and whether the specific device and proposed use fit your situation.
Can I have an anxiety disorder as well as depression?
Yes. Generalized anxiety disorder and depression can occur together. Clarifying both diagnoses helps the clinician decide which treatments are needed and which symptoms should be tracked separately.
Does adult anxious-depression clearance apply automatically to teenagers?
No. Device indications are specific to the population and use. The anxious-depression indication discussed here is for adults; an adolescent treatment proposal requires review of the relevant device labeling and the young person’s clinical needs.
If anxiety remains, does that mean TMS failed completely?
Not necessarily. Improvement in depressive symptoms can still be meaningful, while remaining anxiety needs further assessment and treatment. Review both outcomes rather than judging the whole course from one symptom or one questionnaire score.
Can the team promise that anxiety will improve before depression?
No individual sequence should be promised. Agree on how both symptom groups and daily functioning will be assessed, when progress will be reviewed, and what will happen if the response is incomplete.
Comments